CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM NEW
Total 13F shares
407,050
Share change
+7,560
Total reported value
$676,166
Price per share
$1.66
Number of holders
10
Value change
+$30,531
Number of buys
7
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q1 2020

As of 31 Mar 2020, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 407,050 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, National Asset Management, Inc., WEDBUSH SECURITIES INC, CITADEL ADVISORS LLC, ROYAL BANK OF CANADA, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, and Federation des caisses Desjardins du Quebec. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.